
## **Trustees’ Annual Report for the period** 

**From 02/10/2022             Period start date   To 01/10/2023 Period end date** 

## **Charity name: The Cosmetic Practice Standards Authority** 

**Charity registration number:** 1186220 

## **Objectives and Activities** 

||SORP reference||
|---|---|---|
|Summary of the purposes<br>of the charity as set out in<br>its governing document|Para 1.17|The Cosmetic Practise Standards Authority<br>(CPSA) aims to safeguard the public and<br>patients who undergo non-surgical cosmetic<br>and hair restoration surgery procedures.<br>We aim to protect the health of patients by<br>improving standards of care through the<br>promotion of good practice and the setting<br>of clinical standards. Through this we also<br>promote the importance of professionalism<br>of practitioners. This includes continual<br>professional development, auditing of<br>results, reporting of complications,<br>emphasising the importance of adequate<br>indemnity, consent and psychological<br>wellbeing of patients.<br>We aim to better inform the public, making<br>them aware of the risks and benefits of<br>treatments.|
|Summary of the main<br>activities in relation to those<br>purposes for the public<br>benefit, in particular, the<br>activities, projects or<br>services identified in the<br>accounts.|Para 1.17 and<br>1.19|Creation and publication of cosmetic<br>practice standards. High-level standards,<br>created and ratified by independent<br>professionals, highly commended in their<br>respective fields. These standards are<br>published online:<br>Www.cosmeticstandards.org.uk<br>.<br>The practice standards include: Botulinum<br>toxin, Dermal Fillers, Skin rejuvenation<br>(chemical peels and microneedling), LASER<br>treatments and Hair Restoration Surgery.<br>The standards focusing on professionalism,<br>behaviours, consent, indemnity,<br>qualifications and training.<br>These standards were launched in the<br>House of Lords in February 2018, along<br>with our sister charitable organisation-the|





|||Joint Council of Cosmetic Practitioners<br>(JCCP)<br>The JCCP, use the CPSA standards to<br>benchmark practitioners against. This<br>symbiotic relationship has the overarching<br>aim to safeguard the public.<br>Moving forward the CPSA hopes to<br>strengthen its ties with the JCCP. To ensure<br>viability moving forward, we plan to develop<br>a financial relationship from JCCP, by which<br>an agreed percentage of of the registrant<br>membership fee is paid to us.<br>This agreement will facilitate the further<br>iterations of the standards, ensuring they<br>are contemporaneous and to include novel<br>treatments that pose risks to the public.<br>We plan to respond to the government<br>consultation on practitioner licensing in the<br>hope to further improve patient and public<br>safety in this industry.|
|---|---|---|
|Statement confirming<br>whether the trustees have<br>had regard to the guidance<br>issued by the Charity<br>Commission on public<br>benefit|Para 1.18|We can confirm the trustees have read the<br>guidance.|



## **Additional information (optional)** You may choose to include further statements where relevant about: 

||<br>SORP reference||
|---|---|---|
|Policy on grant making|Para 1.38|N/A|
|Policy on social investment<br>including program related<br>investment|Para 1.38|N/A|
|Contribution made by<br>volunteers|Para 1.38|All Trustees and subcommittee members<br>supply their time and expertise on a<br>voluntary basis. Individuals self fund travel<br>and accommodation where required. As we<br>mature as an organisation this may<br>change.|
|Other||The CPSA was started through the<br>recommendations that stemmed from the<br>Keogh Review of Cosmetic Regulation in<br>2013.<br>The British Association of Plastic<br>Reconstructive and Aesthetic Surgeons|





(BAPRAS), The British Association of Aesthetic Plastic Surgeons (BAAPS) and British Association of Dermatologists (BAD) are the founding parent organisations who set up the CPSA through philanthropic donations of personnel and meeting venues. A seeding fund facilitated the legal fees to constitute the CPSA. These funds were paid directly on behalf of the CPSA and did transfer through a CPSA bank account. 

## **Achievements and Performance** 

||SORP reference||
|---|---|---|
|Summary of the main<br>achievements of the charity,<br>identifying the difference the<br>charity’s work has made to<br>the circumstances of its<br>beneficiaries and any wider<br>benefits to society as a<br>whole.|Para 1.20|The standards are published online:<br>Www.cosmeticstandards.org.uk<br> and are<br>regarded as the_‘gold standard’_in the<br>industry. These are public  and industry<br>facing – shining a light on what clinical<br>standards are required to deliver safe care<br>to patients.<br>The standards were launched in the House<br>of Lords in February 2018, along with our<br>sister charitable organisation - the JCCP.<br>The CPSA and JCCP strongly believe we<br>have raised public awareness of safety<br>issues in the cosmetic industry. Our long<br>term mission is to achieve statutory<br>regulation.<br>A step toward this mission, was the<br>achievement is the passing of the recent<br>passing of the The Botulinum Toxin and<br>Cosmetic Fillers (Children) Act 2021 making<br>it illegal to provide such treatments to under<br>18s for cosmetic purposes.<br>Our Chair, Mr Alexander Woollard also<br>gave evidence at the All Party<br>Parliamentary Group (APPG) for Beauty,<br>Aesthetics and Wellbeing in 2022.<br>This combined approach, of raising public<br>awareness and working with policy makers<br>is protecting patients from harm.|



## **Additional information (optional)** 

You may choose to include further statements where relevant about: 

|Achievements against<br>objectives set|Para 1.41|
|---|---|





|Performance of fundraising<br>activities against objectives<br>set|Para 1.41||
|---|---|---|
|Investment performance<br>against objectives|Para 1.41||
|Other|||





## **Financial Review** 

|**Financial Review**|||
|---|---|---|
|Review of the charity’s<br>financial position at the end<br>of the period|Para 1.21|We currently have no financial in or<br>outgoings. Our Trustees are volunteers.<br>Meeting space and additional personnel is<br>donated through our parent organisations<br>BAPRAS, BAAPS and BAD.|
|Statement explaining the<br>policy for holding reserves<br>stating why they are held|Para 1.22|N/A|
|Amount of reserves held|Para 1.22|N/A|
|Reasons for holding zero<br>reserves|Para 1.22|N/A|
|Details of fund materially in<br>deficit|Para 1.24|N/A|
|Explanation of any<br>uncertainties about the<br>charity continuing as a going<br>concern|Para 1.23|None|



## **Additional information (optional)** 

You may choose to include further statements where relevant about: 

|<br>The charity’s principal<br>sources of funds (including<br>any fundraising)|<br>Para 1.47||
|---|---|---|
|Investment policy and<br>objectives including any<br>social investment policy<br>adopted|Para 1.46||
|A description of the principal<br>risks facing the charity|Para 1.46||
|Other|||





## **Structure, Governance and Management** 

|Description of charity’s<br>trusts:|||
|---|---|---|
|Type of governing document<br>(trust deed, royal charter)|Para 1.25|Foundation constitution|
|How is the charity<br>constituted?<br>(e.g unincorporated<br>association, CIO)|Para 1.25|Charitable Incorporate Organisation (CIO)|
|Trustee selection methods<br>including details of any<br>constitutional provisions e.g.<br>election to post or name of<br>any person or body entitled<br>to appoint one or more<br>trustees|Para 1.25|Trustees are nominated and put forward by<br>the parent organisations – BAPRAS,<br>BAAPS and BAD (please see list of<br>Trustees).<br>The Chair, Mr Alexander Woollard was<br>nominated and put forward by the Trustees<br>and confirmed through a vote at a Board<br>meeting.<br>Mr Alexander Armstrong is the treasurer.<br>Trustee selection and maintenance of<br>Trusteeship guidance criteria is written into<br>our constitution, with fair and agreed<br>representation from our parent societies<br>(which are also charities).<br>We also have non-voting/non-Trustee<br>members present at Board meetings. E.g.<br>JCCP representation, administrative<br>support/secretary Mr Mark Mikhail. Mr Mark<br>Mikhail has now been proposed as a<br>Trustee.<br>Our subcommittees focus on organisational<br>strategy, horizon scanning and clinical<br>specialist groups, which develop the<br>standards.<br>This year Mr Nigel Mercer stepped down as<br>one of the founding Trustees. We thank<br>him for his immense contribution.<br>Mr Ahmed Ali-Khan was proposed by Mr<br>Nigel Mercer to the Board of Trustees. Mr<br>Ali-Khan has a vast amount of experience<br>in the sector. The Board of trustees<br>reviewed this nomination and approved it.<br>Mr Ali-Khan was appointed in January<br>2022. Our changes in Trustee details have<br>been submitted for acknowledgement by<br>the commission.|



## **Additional information (optional)** You may choose to include further statements where relevant about: 

Policies and procedures 

Para 1.51 



adopted for the induction and training of trustees The charity’s organisational structure and any wider Para 1.51 network with which the charity works Relationship with any related Para 1.51 parties Other 

## **Reference and Administrative details** 

|Charity name|Cosmetic Practice Standards Authority|
|---|---|
|Other name the charity uses|CPSA|
|Registered charity number|1186220|
|Charity’s principal address|CPSA<br>Willan House<br>4 Fitzroy Square<br>London<br>W1T 5HQ<br>02073830266<br>http://www.cosmeticstandards.org.uk/<br>cpsastrategygroup@gmail.com|
|||





## **Names of the charity trustees who manage the charity** 

|1<br>2<br>3<br>4<br>5<br>6<br>7|**Trustee name**|**Office (if any)**|**Dates acted if not for whole**<br>**year**|**Name of person (or body) entitled**<br>**to appoint trustee (ifany)**|
|---|---|---|---|---|
||Alexander<br>Woollard|Willan House<br>4 Fitzroy Square<br>London<br>W1T 5HQ||BAAPS|
||Alexander<br>Armstrong|Willan House<br>4 Fitzroy Square<br>London<br>W1T 5HQ||Ex-officio/BAPRAS|
||Simon Withey|Willan House<br>4 Fitzroy Square<br>London<br>W1T 5HQ||BAAPS|
||Ahmed Ali-Khan|Willan House<br>4 Fitzroy Square<br>London<br>W1T 5HQ||BAPRAS|
||Emma Craythorne|Willan House<br>4 Fitzroy Square<br>London<br>W1T 5HQ||BAD|
||Tamara Griffiths|Willan House<br>4 Fitzroy Square<br>London<br>W1T 5HQ||BAD|
||Mark Mikhail|Willan House<br>4 Fitzroy Square<br>London<br>W1T 5HQ||Ex Officio|



– Corporate trustees names of the directors at the date the report was approved 

**Director name** 



Name of trustees holding title to property belonging to the charity 

**Trustee name Dates acted if not for whole year** 



## **Funds held as custodian trustees on behalf of others** 

Description of the assets N/A held in this capacity 

Name and objects of the N/A charity on whose behalf the assets are held and how this falls within the custodian charity’s objects 

Details of arrangements for N/A safe custody and segregation of such assets from the charity’s own assets 

## **Additional information (optional)** 

## **Names and addresses of advisers (Optional information)** 

**Type of Name Address adviser** 

## **Name of chief executive or names of senior staff members (Optional information)** 

## **Exemptions from disclosure** 

Reason for non-disclosure of key personnel details 

**N/A** 

## **Other optional information** 



## **Declarations** 

**The trustees declare that they have approved the trustees’ report above.** 

**Signed on behalf of the charity’s trustees** 

**Signature(s) Full name(s)** Alexander Armstrong 

**Position (eg Secretary,** Treasurer **Chair, etc)** 

**Date** 

27[th] July 2022 




**The Cosmetic Practice Standards Authority 1186220 Receipts and payments accounts CC16a For the period** Period start date Period end date **To from** 10/2/2022 10/1/2023 

## **Section A Receipts and payments** 

|**Section A Receipts and payments**|||||
|---|---|---|---|---|
|**A1 Receipts**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**_Sub total_                               -**<br>**_Total receipts_                           -**<br>**A3 Payments**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**_Sub total_                                -**<br>**-**<br>**-**<br>**_Sub total_                                -**<br>**_Total payments_                           -**<br>**_Net of receipts/(payments)_                           -**<br>**A5 Transfers between funds**<br>**-**<br>**A6 Cash funds last year end**<br>**-**<br>**_Cash funds this year end_                           -**<br>**Unrestricted**<br>**funds**<br>**to the nearest      £**<br>**_Sub total_**_(Gross income for AR)_<br>**A2 Asset and investment sales,**<br>**(see table).**<br>**A4 Asset and investment**<br>**purchases, (see table)**|**to the nearest £**<br>**Restricted**<br>**funds**|**to the nearest £**<br>**Endowment**<br>**funds**|**Total funds**<br>**to the nearest £**|**Last year**<br>**to the nearest £**|
||**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
||||||
||**-**<br>**-**<br>**-**|**-**<br>**-**<br>**-**|**-**<br>**-**<br>**-**||
|||||**-**|
|||||**-**|
||||||
||**-**|**-**|**-**|**-**|
||||||
||**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**|**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
|||||**-**|
||||||
||**-**<br>**-**<br>**-**|**-**<br>**-**<br>**-**|**-**<br>**-**<br>**-**||
||||||
|||||**-**|
||||||
||**-**|**-**|**-**|**-**|
||||||
||**-**<br>**-**<br>**-**<br>**-**|**-**<br>**-**<br>**-**<br>**-**|**-**<br>**-**<br>**-**<br>**-**|**-**|
|||||**-**|
|||||**-**|
|||||**-**|





## **Section B Statement of assets and liabilities at the end of the period** 

|**Categories**<br>**B1 Cash funds**<br>**B2 Other monetary assets**<br>**B3 Investment assets**<br>**B5 Liabilities**<br>**B4 Assets retained for the**<br>**charity’s own use**<br>Signed by one or two trustees on<br>behalf of all the trustees|**Details**<br>**Details**<br>**Details**<br>**Details**<br>**Details**<br>Signature<br>Electronicallyverified. A Armstrong<br>**_Total cash funds_**<br>(agree balances with receipts and payments<br>account(s))|**to nearest £**<br>**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>OK<br>OK<br>**to nearest £**<br>**to nearest £**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Cost (optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**Cost (optional)**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>**-**<br>Print Name<br>Alexander Armstrong<br>**Unrestricted**<br>**funds**<br>**Restricted**<br>**funds**<br>**Unrestricted**<br>**funds**<br>**Restricted**<br>**funds**<br>**Fund to which**<br>**asset belongs**<br>**Fund to which**<br>**asset belongs**<br>**Fund to which**<br>**liability relates**<br>**Amount due**<br>**(optional)**|**to nearest £**<br>**Endowment**<br>**funds**|
|---|---|---|---|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||OK|
||||**to nearest £**<br>**Endowment**<br>**funds**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**Current value**<br>**(optional)**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**Current value**<br>**(optional)**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**-**|
||||**When due**<br>**(optional)**|
|||||
|||||
|||||
|||||
|||||
|||||
||||Date of<br>approval|
||Electronicallyverified. A Armstrong|Alexander Armstrong|7/31/2024|
|||||



